104 related articles for article (PubMed ID: 38850590)
1. Discovery of Protease-activated receptor 2 antagonists derived from phenylalanine for the treatment of breast cancer.
Kim T; Lee Y; Lim H; Kim Y; Cho H; Namkung W; Han G
Bioorg Chem; 2024 May; 150():107496. PubMed ID: 38850590
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
[TBL] [Abstract][Full Text] [Related]
3. Biased signaling: potential agonist and antagonist of PAR2.
Kakarala KK; Jamil K
J Biomol Struct Dyn; 2016 Jun; 34(6):1363-76. PubMed ID: 26295578
[TBL] [Abstract][Full Text] [Related]
4. C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice.
Kume M; Ahmad A; Shiers S; Burton MD; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Apr; 24(4):605-616. PubMed ID: 36417966
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.
Cho NC; Cha JH; Kim H; Kwak J; Kim D; Seo SH; Shin JS; Kim T; Park KD; Lee J; No KT; Kim YK; Lee KT; Pae AN
Bioorg Med Chem; 2015 Dec; 23(24):7717-27. PubMed ID: 26631441
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-2 signaling through β-arrestin-2 mediates Alternaria alkaline serine protease-induced airway inflammation.
Yee MC; Nichols HL; Polley D; Saifeddine M; Pal K; Lee K; Wilson EH; Daines MO; Hollenberg MD; Boitano S; DeFea KA
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1042-L1057. PubMed ID: 30335499
[TBL] [Abstract][Full Text] [Related]
7. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
[TBL] [Abstract][Full Text] [Related]
8. Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.
Tu NH; Jensen DD; Anderson BM; Chen E; Jimenez-Vargas NN; Scheff NN; Inoue K; Tran HD; Dolan JC; Meek TA; Hollenberg MD; Liu CZ; Vanner SJ; Janal MN; Bunnett NW; Edgington-Mitchell LE; Schmidt BL
J Neurosci; 2021 Jan; 41(1):193-210. PubMed ID: 33172978
[TBL] [Abstract][Full Text] [Related]
9. Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) - a promising target for breast cancer.
Kakarala KK; Jamil K; Devaraji V
J Mol Graph Model; 2014 Sep; 53():179-199. PubMed ID: 25173751
[TBL] [Abstract][Full Text] [Related]
10. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking.
Stalheim L; Ding Y; Gullapalli A; Paing MM; Wolfe BL; Morris DR; Trejo J
Mol Pharmacol; 2005 Jan; 67(1):78-87. PubMed ID: 15475570
[TBL] [Abstract][Full Text] [Related]
11. Protease activated receptor-2 (PAR2): possible target of phytochemicals.
Kakarala KK; Jamil K
J Biomol Struct Dyn; 2015 Sep; 33(9):2003-22. PubMed ID: 25386994
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.
Tsai CC; Chou YT; Fu HW
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):486-503. PubMed ID: 30321617
[TBL] [Abstract][Full Text] [Related]
13. Secreted gingipains from Porphyromonas gingivalis induce microglia migration through endosomal signaling by protease-activated receptor 2.
Nonaka S; Nakanishi H
Neurochem Int; 2020 Nov; 140():104840. PubMed ID: 32858090
[TBL] [Abstract][Full Text] [Related]
14. Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational Modeling.
Kennedy AJ; Ballante F; Johansson JR; Milligan G; Sundström L; Nordqvist A; Carlsson J
ACS Pharmacol Transl Sci; 2018 Nov; 1(2):119-133. PubMed ID: 32219208
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition.
Kennedy AJ; Sundström L; Geschwindner S; Poon EKY; Jiang Y; Chen R; Cooke R; Johnstone S; Madin A; Lim J; Liu Q; Lohman RJ; Nordqvist A; Fridén-Saxin M; Yang W; Brown DG; Fairlie DP; Dekker N
Commun Biol; 2020 Dec; 3(1):782. PubMed ID: 33335291
[TBL] [Abstract][Full Text] [Related]
17. The protease activated receptor 2 (PAR2) polymorphic variant F240S constitutively activates PAR2 receptors and potentiates responses to small-molecule PAR2 agonists.
Ma JN; Burstein ES
J Pharmacol Exp Ther; 2013 Dec; 347(3):697-704. PubMed ID: 24078870
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
[TBL] [Abstract][Full Text] [Related]
19. PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expression.
Jiang Y; Zhuo X; Wu Y; Fu X; Mao C
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119144. PubMed ID: 34599981
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cells.
Carvalho É; Hugo de Almeida V; Rondon AMR; Possik PA; Viola JPB; Monteiro RQ
Biochem Biophys Res Commun; 2018 Sep; 504(1):270-276. PubMed ID: 30172372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
